{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:03:47Z","timestamp":1775282627325,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00432-018-2613-9","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T14:57:53Z","timestamp":1519225073000},"page":"935-943","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma"],"prefix":"10.1007","volume":"144","author":[{"given":"L\u00e1szl\u00f3","family":"Pincz\u00e9s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zs\u00f3fia","family":"Milt\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1rp\u00e1d","family":"Ill\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1200\/JCO.1993.11.2.225","volume":"11","author":"S Bodis","year":"1993","unstructured":"Bodis S, Henry-Amar M, Bosq J et al (1993) Late relapse in early-stage Hodgkin\u2019s disease patients enrolled on European Organization for Research and Treatment of Cancer protocols. J Clin Oncol 11:225\u2013232","journal-title":"J Clin Oncol"},{"key":"2613_CR2","unstructured":"Brierley JD, Rathmell AJ, Gospodarowicz MK et al (1997) Late relapse after treatment for clinical Stage I and II Hodgkin\u2019s disease. Cancer 79:1422\u20131427. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19970401)79:7<1422::AI D-CNCR20>3.0.CO;2-0"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3324\/haematol.2015.130849","volume":"101","author":"PJ Br\u00f6ckelmann","year":"2016","unstructured":"Br\u00f6ckelmann PJ, Gr\u00f6gen H, Kohnhorst C et al (2016) Very late relapse 5 years after first diagnosis of Hodgkin lymphoma: an analysis of the German Hodgkin Study Group HD7-HD12 trials. Haematologica 101:46","journal-title":"Haematologica"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1200\/JCO.2016.71.3289","volume":"35","author":"PJ Br\u00f6ckelmann","year":"2017","unstructured":"Br\u00f6ckelmann PJ, Goergen H, Kohnhorst C et al (2017) Late relapse of classical Hodgkin lymphoma: an analysis of the German Hodgkin Study Group HD7 to HD12 Trials. J Clin Oncol 35:1444\u20131450. https:\/\/doi.org\/10.1200\/JCO.2016.71.3289","journal-title":"J Clin Oncol"},{"key":"2613_CR5","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1182\/blood.V84.8.2447.2447","volume":"84","author":"P Brousset","year":"1994","unstructured":"Brousset P, Schlaifer D, Meggetto F et al (1994) Persistence of the same viral strain in Early and Late Relapses of Epstein\u2013Barr virus-associated Hodgkin\u2019s disease. Blood 84:2447\u20132451","journal-title":"Blood"},{"key":"2613_CR6","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K et al (1971) Report of the Committee on Hodgkin\u2019s disease staging classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"2613_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bjh.12687","volume":"164","author":"EJ Dann","year":"2014","unstructured":"Dann EJ, Berkahn L, Mashiach T et al (2014) Hodgkin lymphoma patients in first remission: routine positron emission tomography\/computerized tomography imaging is not superior to clinical follow-up for patients with no residual mass. Br J Haematol 164:694\u2013700. https:\/\/doi.org\/10.1111\/bjh.12687","journal-title":"Br J Haematol"},{"key":"2613_CR8","first-page":"493","volume":"29","author":"\u0130 Dilek","year":"1999","unstructured":"Dilek \u0130, G\u00fcrman G, Kuzu I, Erekul S (1999) Very late relapse in Hodgkin\u2019s disease. Tr J Med Sci 29:493\u2013496","journal-title":"Tr J Med Sci"},{"key":"2613_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3324\/haematol.2011.056010","volume":"97","author":"TC El-Galaly","year":"2012","unstructured":"El-Galaly TC, Mylam KJ, Brown P et al (2012) Positron emission tomography\/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs. Haematologica 97:931\u2013936. https:\/\/doi.org\/10.3324\/haematol.2011.056010","journal-title":"Haematologica"},{"key":"2613_CR10","doi-asserted-by":"crossref","unstructured":"Garcia-Carbonero R, Paz-Ares L, Arcediano A et al (1998) Favorable prognosis after late relapse of hodgkin\u2019s disease. Cancer 83:560\u2013565. https:\/\/doi.org\/10.1002\/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<560::AID-CNCR26>3.0.CO;2-T"},{"key":"2613_CR11","doi-asserted-by":"publisher","first-page":"707542","DOI":"10.1155\/2011\/707542","volume":"2011","author":"F Gaudio","year":"2011","unstructured":"Gaudio F, Giordano A, Pavone V et al (2011) Outcome of Very Late Relapse in Patients with Hodgkin\u2019s Lymphomas. Adv Hematol 2011:707542. https:\/\/doi.org\/10.1155\/2011\/707542","journal-title":"Adv Hematol"},{"key":"2613_CR12","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/mpo.2950120218","volume":"12","author":"JA Green","year":"1984","unstructured":"Green JA, Arnold AM, Macbeth FR et al (1984) Late recurrence in Hodgkin\u2019s disease: a report of two cases. Med Pediatr Oncol 12:148\u2013149","journal-title":"Med Pediatr Oncol"},{"key":"2613_CR13","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17:3835\u20133849","journal-title":"J Clin Oncol"},{"key":"2613_CR14","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000227474","volume":"52","author":"A Ill\u00e9s","year":"1995","unstructured":"Ill\u00e9s A, B\u00e1nyai A, Vad\u00e1sz G, Szegedi G (1995) Relapse of Hodgkin\u2019s disease after ten years. Oncology 52:284\u2013286","journal-title":"Oncology"},{"key":"2613_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/bjh.13943","volume":"173","author":"LH Jakobsen","year":"2016","unstructured":"Jakobsen LH, Hutchings M, de Nully Brown P et al (2016) No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study. Br J Haematol 173:236\u2013244. https:\/\/doi.org\/10.1111\/bjh.13943","journal-title":"Br J Haematol"},{"key":"2613_CR16","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bbmt.2011.08.012","volume":"18","author":"SF Keller","year":"2012","unstructured":"Keller SF, Kelly JL, Sensenig E et al (2012) Late relapses following high-dose autologous stem cell transplantation (HD-ASCT) for Hodgkin\u2019s lymphoma (HL) in the ABVD therapeutic era. Biol Blood Marrow Transpl 18:640\u2013647. https:\/\/doi.org\/10.1016\/j.bbmt.2011.08.012","journal-title":"Biol Blood Marrow Transpl"},{"key":"2613_CR17","first-page":"637","volume":"11","author":"M Kutchuk","year":"2009","unstructured":"Kutchuk M, Edelstein Y, Ellis MH (2009) Late relapse of Hodgkin\u2019s lymphoma presenting as fatal hematemesis caused by an esophago\u2013tracheo\u2013arterial fistula. Isr Med Assoc J 11:637\u2013638","journal-title":"Isr Med Assoc J"},{"key":"2613_CR18","doi-asserted-by":"crossref","unstructured":"Lazarovici J, Dartigues P, Brice P et al (2015) Nodular lymphocyte predominant Hodgkin lymphoma: a lymphoma study association retrospective study. Haematologica 100","DOI":"10.3324\/haematol.2015.133025"},{"key":"2613_CR19","doi-asserted-by":"crossref","unstructured":"Lee KM, Spittle MF (1993) Hodgkin\u2019s disease: a case of late relapse. Clin Oncol 5","DOI":"10.1016\/S0936-6555(05)80098-6"},{"key":"2613_CR20","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","volume":"7","author":"TA Lister","year":"1989","unstructured":"Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting. J Clin Oncol 7:1630\u20131636","journal-title":"J Clin Oncol"},{"key":"2613_CR21","first-page":"1311","volume":"26","author":"RJ Lukes","year":"1966","unstructured":"Lukes RJ, Craver LF, Hall TC et al (1966) Report of the nomenclature committee. Cancer Res 26:1311\u20131311","journal-title":"Cancer Res"},{"key":"2613_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12955-017-0758-x","volume":"15","author":"F Magyari","year":"2017","unstructured":"Magyari F, K\u00f3sa K, Berecz R et al (2017) Employment status and health related quality of life among Hodgkin-lymphoma survivors\u2019\u2014results based on data from a major treatment center in Hungary. Health Qual Life Outcomes 15:180. https:\/\/doi.org\/10.1186\/s12955-017-0758-x","journal-title":"Health Qual Life Outcomes"},{"key":"2613_CR23","first-page":"750","volume":"101","author":"O Markovic","year":"2016","unstructured":"Markovic O, Andjelic B (2016) Late relapse of Hodgkin lymphoma\u2014is it different in clinical characteristics and outcome? Haematologica 101:750","journal-title":"Haematologica"},{"key":"2613_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12032-007-9012-4","volume":"25","author":"BS Mihaljevic","year":"2008","unstructured":"Mihaljevic BS, Jovanovic MDP, Jakovic LR et al (2008) Hodgkin\u2019s lymphoma relapse in the uterine cervix 15 years after the initial cure. Med Oncol 25:245\u2013247. https:\/\/doi.org\/10.1007\/s12032-007-9012-4","journal-title":"Med Oncol"},{"key":"2613_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18103\/mra.v4i6.658","volume":"4","author":"L Pincz\u00e9s","year":"2016","unstructured":"Pincz\u00e9s L, Milt\u00e9nyi Z, J\u00f3na \u00c1 et al (2016) How the epidemiology of Hodgkin lymphoma changed in Debrecen, Hungary. Med Res Arch 4:1\u201313. https:\/\/doi.org\/10.18103\/mra.v4i6.658","journal-title":"Med Res Arch"},{"key":"2613_CR26","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3109\/10428194.2010.500432","volume":"51","author":"M Provencio","year":"2010","unstructured":"Provencio M, Salas C, Mill\u00e1n I et al (2010) Late relapses in Hodgkin lymphoma: a clinical and immunohistochemistry study. Leuk Lymphoma 51:1686\u20131691. https:\/\/doi.org\/10.3109\/10428194.2010.500432","journal-title":"Leuk Lymphoma"},{"key":"2613_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1097\/00000421-200112000-00009","volume":"24","author":"S Shihabi","year":"2001","unstructured":"Shihabi S, Deutsch M, Jacobs SA (2001) Very late relapse of Hodgkin\u2019s disease. Am J Clin Oncol 24:576\u2013578. https:\/\/doi.org\/10.1097\/00000421-200112000-00009","journal-title":"Am J Clin Oncol"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/10428199709109166","volume":"26","author":"R Siebert","year":"1997","unstructured":"Siebert R, Fossa A, Kaiser W et al (1997) Recurrence of Hodgkin\u2019s disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB 1 *0301 = Linked Susceptibility? Leuk Lymphoma 26:121\u2013125","journal-title":"Leuk Lymphoma"},{"key":"2613_CR29","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA et al (2009) The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937\u2013951. https:\/\/doi.org\/10.1182\/blood-2009-03-209262","journal-title":"Blood"},{"key":"2613_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3324\/haematol.2015.135434","volume":"101","author":"TP Vassilakopoulos","year":"2016","unstructured":"Vassilakopoulos TP, Pangalis GA, Dimopoulou MN et al (2016) Very late relapses occuring at least 5 years after the initiation of treatment with chemotherapy or combined modality therapy in patients with Hodgkin: incidence, risk factors and outcome. Haematologica 101:52","journal-title":"Haematologica"},{"key":"2613_CR31","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1182\/blood.V126.23.2697.2697","volume":"126","author":"S Viviani","year":"2015","unstructured":"Viviani S, Mussetti A, Bartolo O, Di et al (2015) Late relapse in Hodgkin lymphoma (HL): a retrospective analysis of patients enrolled on clinical trials at the Istituto Nazionale Tumori of Milan (INT-MI). Blood 126:2697","journal-title":"Blood"},{"key":"2613_CR32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell R (2011) Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev 7:214\u2013220","journal-title":"Curr Cardiol Rev"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-018-2613-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-018-2613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T11:29:02Z","timestamp":1603884542000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-018-2613-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s00432-018-2613-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,21]]},"assertion":[{"value":"29 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Regional and Institutional Ethics Committee, Clinical Center, University of Debrecen. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants or legally authorized representatives of participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}